0001213900-20-022562.txt : 20200817
0001213900-20-022562.hdr.sgml : 20200817
20200817190211
ACCESSION NUMBER: 0001213900-20-022562
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20200813
FILED AS OF DATE: 20200817
DATE AS OF CHANGE: 20200817
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Kaplan Myron
CENTRAL INDEX KEY: 0001672645
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-34673
FILM NUMBER: 201111206
MAIL ADDRESS:
STREET 1: C/O KLEINBERG, KAPLAN, WOLFF & COHEN, PC
STREET 2: 551 FIFTH AVENUE, 18TH FLOOR
CITY: NEW YORK
STATE: NY
ZIP: 10176
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: CorMedix Inc.
CENTRAL INDEX KEY: 0001410098
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 400 CONNELL DRIVE
STREET 2: SUITE 5000
CITY: BERKELEY HEIGHTS
STATE: NJ
ZIP: 07922
BUSINESS PHONE: 908-517-9500
MAIL ADDRESS:
STREET 1: 400 CONNELL DRIVE
STREET 2: SUITE 5000
CITY: BERKELEY HEIGHTS
STATE: NJ
ZIP: 07922
4
1
doc4.xml
PRIMARY DOCUMENT
X0306
4
2020-08-13
false
0001410098
CorMedix Inc.
CRMD
0001672645
Kaplan Myron
C/O CORMEDIX INC.
400 CONNELL DRIVE, SUITE 5000
BERKELEY HEIGHTS
NJ
07922
true
false
false
false
Common Stock
2020-08-13
4
P
false
15000.0000
4.0773
A
134734.0000
D
Stock Option (Right to Buy Common Stock)
5.6300
2030-02-25
Common Stock
15000.0000
15000.0000
D
Stock Option (Right to Buy Common Stock)
8.3000
2029-01-10
Common Stock
15000.0000
15000.0000
D
Stock Option (Right to Buy Common Stock)
2.8500
2028-02-16
Common Stock
8000.0000
8000.0000
D
Stock Option (Right to Buy Common Stock)
11.2000
2027-02-21
Common Stock
8000.0000
8000.0000
D
Stock Option (Right to Buy Common Stock)
21.4000
2026-04-28
Common Stock
10000.0000
10000.0000
D
This transaction was executed in multiple trades at prices ranging from $4.04 to $4.0899. The price reported in Column 4 is a weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected.
These options were granted on 02/25/2020. The options vest monthly with full vesting on the one year anniversary of the date of grant, subject to continued service on the board.
These options were granted on 01/10/2019. These options are fully vested.
These options were granted on 02/16/2018. These options are fully vested.
These options were granted on 02/21/2017. These options are fully vested.
These options were granted on 4/28/2016. These options are fully vested.
The Issuer effected a 1-for-5 reverse stock split of its common stock on March 26, 2019. All share and per share exercise price amounts shown in this Form 4 have been adjusted to reflect the reverse stock split.
/s/ Myron Kaplan
2020-08-17